A look at the clinical progress of anti-Aβ monoclonal antibodies and how precision delivery is shaping the next generation of ...
A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...
"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...
News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and ...
Lithium deficiency in the brain could be a cause of Alzheimer's disease—and a new potential target for treatment. Ten years in the making, this is the finding of researchers at Harvard Medical School ...
Primary care physicians (PCPs) in Ontario frequently used diagnostic tools to assess patients for Alzheimer’s disease and dementia, with usage increasing during follow-up. Antidepressants were ...
On its own, LATE dementia is less severe than Alzheimer’s, but in combination, it makes Alzheimer’s symptoms worse, scientists say. Doctors told Ray Hester he was in the beginning stages of ...
A recent study from Harvard Medical School asks whether the element lithium might be a key factor in whether someone develops Alzheimer's disease. Led by Dr. Bruce Yankner, professor of genetics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results